Guiding Novel Neurologic Drug Approvals

The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.

Malignant Hyperthermia: An Overview

Malignant hyperthermia must be treated rapidly to avoid fatality, and despite its rarity, healthcare facilities that use known triggering agents must be fully prepared to treat it.

Tylenol Cold & Flu Q&A

Quick Poll

How well is the Poll admin working for you?